#1
|
|||
|
|||
Ôàðìàòåêñ è ïàòåíòåêñ îâàë
Íà óïàêîâêå óêàçàíî, ÷òî Ôàðìàòåêñ è ïàòåíòåêñ îâàë - íåãîðìîíàëüíûûå ñðåäñòâà êîíòðàöåïöèè... íî ìîÿ ïîäðóãà çíà÷èòåëüíî ïðèáàâèëà â âåñå ïîñëå 2-õ ëåò ïðèìåíåíèÿ ýòèõ ïðåïàðàòîâ (ðàöèîí ïèòàíèÿ è îáðàç æèçíè íå èçìåíèëñÿ). Îíà óâåðåíà, ÷òî ýòè ñðåäñòâà ãîðìîíàëüíûå. Òàê ëè ýòî? È ìîæíî ëè èõ ïðèìåíÿòü â òå÷åíèå íåñêîëüêèõ ëåò?
|
#2
|
||||
|
||||
Öèòàòà:
Ôàðìàòåêñ- Áåíçàëêîíèóì õëîðèä Ïàòåíòåêñ- Íîí-îêñèëîí-9 Ê ãîðìîíàì ýòè âåùåñòâà íèêàêîãî îòíîøåíèÿ íå èìåþò. Èùèòå ïðè÷èíó ïðèáàâêè âåñà â äðóãîì. Äàííûå ïðåïàðàòû ìîæíî ïðèìåíÿòü äëèòåëüíîå âðåìÿ, åñòü åùå îäèí î÷åíü ïîëåçíûé ýôôåêò - îäíîâðåìåííî ñ ïðîòèâîçà÷àòî÷íûì ýôôåêòîì -ñïîñîáíû óíè÷òîæàòü ïàòîãåííóþ ôëîðó (âêëþ÷àÿ ÂÈ×), íå ïîäàâëÿÿ íîðìàëüíîé âëàãàëèùíîé ôëîðû. |
#3
|
||||
|
||||
Âîò ïðî ÂÈ× âû, ïî-ìîåìó, ïðèóâeëè÷èâàåòå.
Ýòè ñðåäñòâà õîðîøè äëÿ ïðåäîõðàíåíèÿ îò áåðåìåííîñòè, íî íå îò çàáîëåâàíèé (ïðè ñëó÷àéíûõ ïîëîâûõ ñâÿçÿõ, íàïðèìåð). Ðàçâå íåò? |
#4
|
||||
|
||||
Öèòàòà:
|
#5
|
||||
|
||||
ß ðàáîòàþ â êëèíèêå, êîòîðàÿ ñïåöèàëèçèðóåòñÿ íà ñðåäñòâàõ êîíòðàöåïöèè, óæå áîëüøå 10 ëåò. Ìíîãî÷èñëåííûå íàáëþäåíèÿ ïîêàçûâàþò, ÷òî ó æåíùèí, êîòîðûå ïîëüçóþòñÿ ñïåðìèöèäàìè, ãîðàçäî ðåæå âûÿâëÿåòñÿ è ñêðûòàÿ èíôåêöèÿ, è áàíàëüíûå êîëüïèòû îáõîäÿò ñòîðîíîé.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îäíà èç ôðàç òàì çâó÷èò ïðèáëèçèòåëüíî òàê:Benzalkonium ìîùíûé àíòèñåïòèê, êîòîðûé ìîæåò ñíèæàòü àãðåññèâíîñòü âîçáóäèòåëåé çàáîëåâàíèé, ïåðåäàþùèõñÿ ïîëîâûì ïóòåì, íå íàðóøàÿ ïðè ýòîì åñòåñòâåííóþ ìèêðîôëîðó âëàãàëèùà. Ïî ïîâîäó ÂÈ× - ÿ ïðèâåëà äàííûå ïðîèçâîäèòåëÿ. Õîòÿ äåéñòâèòåëüíî, ìíîãèå ýòî îñïàðèâàþò. Âîò åùå ññûëî÷êà: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#6
|
||||
|
||||
Ýòîãî íåäîñòàòî÷íî ÷òîáû ðåêîìåíäîâàòü æåíùèíàì âûøåóêàçàííûé ïðåïàðàò êàê ñðåäñòâî, çàùèùàþùåå îò èíôåêöèé. Îñîáåííî îò HIV, ó÷èòûâàÿ ìàñøòàá ðàñïîñòðàíåííîñòè èíôèöèðîâàíèÿ â Ðîññèè. Èíòåðåñíî, çíàåò ëè ÂÎÇ î áåçîòâåòñòâåííûõ çàÿâëåíèÿõ ïðîèçâîäèòåëåé? Ìîæåò, ýòî îäíà èç ïðè÷èí ðîñòà çàáîëåâàåìîñòè ÑÏÈÄ â Ðîññèè?
|
#7
|
||||
|
||||
Öèòàòà:
|
|
#8
|
||||
|
||||
Êîòîðûé ñóùåñòâóåò â îñíîâíîì â óìàõ ïðîèçâîäèòåëåé.
|
#9
|
||||
|
||||
Öèòàòà:
|
#10
|
|||
|
|||
Ñòîï. Ïðîñòèòå õèðóðãà, íî êàæåòñÿ ðå÷ü èä¸ò íå î ïðåïàðàòå, ïðåäîõðàíÿþùåì îò èíôåêöèé, à î ïðîòèâîçà÷àòî÷íîì ñðåäñòâå, ñïîñîáíûì (õîòü òåîðåòè÷åñêè, õîòü èíâèòðî) îáëåã÷èòü îðãàíèçìó áîðüáó ñî ñëó÷àéíîé èíôåêöèåé. Ïðîñòî ñèìóëüòàííî, ò.ñ., "çà îäíî".
Ò.å. åñëè æåíùèíå äðóãèå ñðåäñòâà ïðåäîõðàíåíèÿ îò ÁÅÐÅÌÅÍÍÎÑÒÈ íå íðàâÿòñÿ, íå ïîäõîäÿò (ïî ðàçíûì ïðè÷èíàì) òî "ëèøàòü å¸ ýòîãî ñðåäñòâà (ìîë, íè÷åãî îíî íå óáèâàåò ÂÈ×) - çíà÷èò ïîâåðíóòü å¸ íà ïóòü, íàïðèìåð, ôèçèîëîãè÷åñêîé êîíòðàöåïöèè (èëè äàæå àíòèôèçèîëîãè÷åñêîé), ÷òî ìîæåò ïðèâåñòè ê íåæåëàòåëüíîé áåðåìåííîñòè, àáîðòó, îñëîæíåíèÿì àáîðòà, áåñïëîäèþ... |
#11
|
||||
|
||||
Ïîýòîìó è íóæíî ãîâîðèòü îá ýòîì ïðåïàðàòå êàê î ïðîòèâîçà÷àòî÷íîì, è íå óïîìèíàòü îá HIV. Ëó÷øå ðàññêàçàòü íàñêîëüêî åãî ýôôåêòèâíîñòü ìåíüøå/áîëüøå ÎÊ è IUD. Áåçîïàñíîñòü òîæå ìîæíî ñðàâíèòü.
Sorry. |
#12
|
|||
|
|||
Óâàæàåìàÿ Zetka,
Èçáèðàòåëüíàÿ òîêñè÷íîñòü õëîðèäà áåíçàëêîíèÿ íà ïàòîãåííóþ ôëîðó - íå äîêàçàííûé íàó÷íûé ôàêò. ÈÍÔÎÐÌÀÖÈß ÄËß ÂÐÀ×ÅÉ: Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina) Dorothy L. Patton PhDa, Gretchen Ganzle Kiddera, Yvonne Cosgrove Sweeneya, Lorna K. Rabeb and Sharon L. Hillier PhDb Seattle, Washington, and Pittsburgh, Pennsylvania From the Department of Obstetrics and Gynecology, University of Washington,a and the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh/Magee-Womens Hospital.b Abstract Objective: Safe and effective vaginally applied microbicides could help to control the continuing spread of sexually transmitted diseases. Study Design: This study used nonhuman primates to test the effects of multiple applications of nonoxynol 9, benzalkonium chloride, or a combination on vaginal flora and lower reproductive tract tissues. Fourteen monkeys (Macaca nemestrina) received daily vaginal applications of nonoxynol 9, benzalkonium chloride, or both for 3 to 4 days. Vaginal microflora and colposcopic observations were made at baseline and during and after completion of treatments. Cervical biopsy specimens were collected from a subset of animals. Results: Cervical erythema and vaginal erythema were observed in all 3 treatment groups. Cervical papillae and epithelial disruption were present in both the nonoxynol 9 and the nonoxynol 9 plus benzalkonium chloride groups. Vaginal epithelial disruption was noted in both the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Cervical biopsy specimens from each group revealed acute inflammatory infiltrates with occasional plasma cells and lymphoid follicles. Detection of most microorganisms, including viridans streptococci, decreased in the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Detection of Lactobacillus species decreased in the benzalkonium chloride group. All microflora levels recovered after several days without microbicide use. Conclusions: Although nonoxynol 9 is currently the only microbicide approved for use as a spermicide in the United States, its repeated use may be detrimental to the epithelial tissues of the female reproductive tract. Benzalkonium chloride, currently approved for use in other countries, not only may damage epithelial tissues but also appears to reduce the population of potentially protective Lactobacillus species in the vagina. (Am J Obstet Gynecol 1999;180:1080-7.) |
#13
|
||||
|
||||
Öèòàòà:
Ãåëü íîíîêñèíîë îêàçàëñÿ íåýôôåêòèâåí äëÿ ïðîôèëàêòèêè çàáîëåâàíèé, ïåðåäàþùèõñÿ ïîëîâûì ïóòåì [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] N-9 cannot be recommended for HIV and STI prevention. |
#14
|
|||
|
|||
Óâàæàåìûé Ëîðä,
Ìíå òîëüêî ÷òî ñäåëàëè çàìå÷àíèå (âåñüìà ñïðàâåäëèâîå), ÷òî íå ñëåäóåò çàãðóæàòü ïàöèåíòà àíãëîÿçû÷íûìè ññûëêàìè (òåì áîëåå èç íàó÷íûõ ðàáîò). Äàâàéòå ïåðåíåñ¸ì òåìó â äðóãîå ìåñòî. |
#15
|
||||
|
||||
Öèòàòà:
|